Slide 1: Third Quarter 2022 Results
Third Quarter 2022 Results 11.10.2022
Slide 2: Forward-Looking Statements
Forward-Looking Statements Certain statements in this presentation are “forward-looking statements” within the meaning of the Private Securities Industry, Market and Other Data Litigation Reform Act of 1995, particularly those regarding our 2022 Financial Guidance. Such forward-looking Certain infor
Slide 3: Risk Factors
Risk Factors The following factors, among others, could cause our business, prospects, financial condition, operating results and cash flows to be materially adversely affected: • Our fax and healthcare interoperability solutions constitute substantially all of our revenue and operating income. • Re
Slide 4: Business Overview
Business Overview
Slide 5: Operating results
Operating results • Record Sales Quarter • ECFax • $8.3M in booked ACV • VA Authority to Operate (ATO) achieved • 62% increase sequentially, 78% increase v. Q3 • First sites targeted for roll out 2021 • Pipeline expands with additional government opportunities • Unite interoperability sales • $1.0M
Slide 6: Third Quarter 2022 Results
Third Quarter 2022 Results
Slide 7: Corporate Revenue – 9th Consecutive Quarter of Revenue and ARPA Growth
Corporate Revenue – 9th Consecutive Quarter of Revenue and ARPA Growth Consensus Corporate Revenue ($ in M) Quarter Ended Q3’21 Q3’22 YoY ~19% Accounts 45 47 5.0% YoY $51.2 (000’s) Growth $43.2 ARPA(1) $314.69 $364.82 15.9% Paid Adds 3 4 14.3% (000’s) ~40% Monthly Account Churn~60% 3.20% 1.71% 46.5%
Slide 8: SoHo Revenue – Operates within Expectations
SoHo Revenue – Operates within Expectations Consensus SoHo Revenue ($ in M ) Quarter Ended Q3’21 Q3’22 YoY -2.7% $45.9 YoY Growth $44.7 Accounts 1,064 978 -8.1% (000’s) ARPA(1) $14.34 $15.06 5.0% Paid Adds 98 86 -12.2% (000’s) ~40% Monthly Account 3.21% 3.60% -12.3% Churn ~60% ~51% Q3'21 Q3'22 YoY S
Slide 9: Q3 2022 Delivers Solid Results on Revenues, PF Adjusted EBITDA and EPS
Q3 2022 Delivers Solid Results on Revenues, PF Adjusted EBITDA and EPS (in $M, except PF Adjusted EPS) Revenue PF Adjusted EBITDA (1) $100.0 $52.5 PF Adjusted EPS (2) $1.60 $95.9 $95.0 $52.0 $1.52 $1.55 $89.2 $51.3 7.5% $90.0 $51.5 $1.50 5.6% $50.9 0.8% $51.0 $1.44 $1.45 $85.0 53.5% $80.0 57.0% Marg
Slide 10: 2022 Financial Guidance
2022 Financial Guidance
Slide 11: Reaffirming Full Year 2022 Guidance Range
REAFFIRMING FULL YEAR 2022 Guidance Range 2022 Full Year EPS Guidance Low Midpoint High Revenue ($M) (1) $375 $380 $385 Adjusted Non-GAAP EBITDA ($M) (1) $201 $204 $207 Adjusted Non-GAAP EPS (2) $5.36 $5.44 $5.50 (1) Figures are Adjusted Non-GAAP (2) Adjusted Non-GAAP EPS (earnings per diluted share
Slide 12: Appendix
Appendix
Slide 13: Consensus PF Consolidated Metrics
Consensus PF Consolidated Metrics 2020 2021 2022 Consensus Metrics Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Revenue by Type |--------(in '000s)--------| Fixed Revenues 60,414 61,376 62,095 63,187 62,645 63,387 63,986 63,440 64,423 66,271 68,702 Variable Revenues 20,573 19,252 21,869 21,998 23,883 24,364 25,
Slide 14: Consensus PF Metrics – Corporate and SoHo
Consensus PF Metrics – Corporate and SoHo 2020 2021 2022 Corporate Fax Metrics Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Revenue by Type |--------(in '000s)-----| Fixed Revenues 20,580 21,151 21,342 22,573 22,497 22,943 23,355 23,485 25,279 27,502 29,079 Variable Revenues 15,504 14,219 16,625 16,986 18,656 1